Fractional Laser Resurfacing Patents: Who Leads, Where Gaps Are 2026
Fractional Laser Resurfacing Patents: Leaders, Filing Trends and Open Claim Space
45.5% concentration at the top. The five leading assignees hold 429 of 942 records in scope — a field where a handful of players occupy nearly half the claim space. Annual filings moved from 43 in 2017 to a peak of 51 in 2022. The most recent complete comparison — 39 records in 2021 against 33 in 2024 — shows a -15% shift over that three-year span. 2025 and 2026 figures are still incomplete under the roughly 18-month publication lag and should not be read as a continued decline.
- 1THE GENERAL HOSPITAL CORP178
- 2CYTRELLIS BIOSYST99
- 3LUMENIS BE LTD57
- 4CYNOSURE INC50
- 5RELIANT TECH INC45
See the full fractional laser resurfacing analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about fractional laser resurfacing patents
Who holds the most patents in fractional laser resurfacing?
The assignee ranking for this dataset of 942 records shows one organisation clearly ahead of the field, with a record count well above the fifth-ranked and tenth-ranked assignees. The top five assignees combined hold 429 records, 45.5% of all records in scope, meaning core mechanisms are concentrated rather than evenly spread. Anyone entering this space should expect to negotiate around or design past claims held by this small leading group before looking at the long tail of smaller filers.
Is fractional laser resurfacing patent activity growing or slowing?
Annual filings rose through the late 2010s and peaked at 51 records in 2022. The most reliable recent comparison, 2021 against 2024, shows a -15% change, a real but modest cooling rather than a collapse. Figures for 2025 and 2026 are still incomplete because publication typically lags actual filing by around 18 months, so it is too early to call this a sustained decline.
What technology areas dominate fractional laser resurfacing patents?
Classification data shows A61B, covering surgical and diagnostic apparatus, present on 66.9% of the 942 records in scope, making it by far the dominant category. A61N, electrotherapy and radiation therapy, follows at 28.7%, and A61K medicinal preparations at 22.3%. Notably, H01S, the class specific to lasers and stimulated emission hardware, appears on only 5.9% of records, indicating that most patented value lies in delivery and tissue-interaction methods rather than in the laser source itself.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Fractional Laser Resurfacing covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.